A molecular pathway analysis informs the genetic background at risk for schizophrenia

Area of Science:

• Genetics
• Neuroscience
• Immunology

Background:

• Schizophrenia is a complex mental disorder affecting thinking and emotional responsiveness.
• Genetic factors are implicated in the biological mechanisms underlying schizophrenia.
• A genetic perspective is crucial for understanding disrupted molecular pathways in schizophrenia.

Purpose of the Study:

• To identify molecular pathways associated with schizophrenia using genetic data.
• To investigate the enrichment of these pathways in patients with schizophrenia.
• To uncover the genetic underpinnings of schizophrenia.

Main Methods:

• Collected genetic loci data previously associated with schizophrenia.
• Identified genes within these loci and mapped their metabolic pathways.
• Performed pathway enrichment analysis using a large sample of patients and controls (4486 and 4477, respectively).

Main Results:

• Identified an enriched molecular pathway associated with schizophrenia (permutated p < 10e-05).
• Found 60 single nucleotide polymorphisms (SNPs) across 30 genes strongly associated with schizophrenia.
• Associated genes are involved in neurodevelopment, apoptosis, vesicle transport, immune response, and MAPK signaling.

Conclusions:

• The toll-like receptor pathway plays a central role in modulating pathways disrupted in schizophrenia.
• This pathway is linked to the innate immune system.
• Immunological events are increasingly recognized as contributing to schizophrenia risk.